Vericel (VCEL) Current Assets (2010 - 2026)
Vericel recorded quarterly Current Assets of $244.1 million in Q1 2026, down 1.36% quarter-over-quarter from $247.4 million in Q4 2025, and up 23.49% year-over-year from $197.6 million in Q1 2025.
Vericel's Current Assets history runs 17 years deep, the most recent figure standing at $244.1 million for Q1 2026.
- In Q1 2026, Current Assets rose 23.49% year-over-year to $244.1 million; the TTM figure through Mar 2026 stood at $244.1 million (up 23.49% YoY), while the FY2025 annual figure was $247.4 million, up 16.29% from the prior year.
- Current Assets came in at $244.1 million for Q1 2026 at Vericel, down from $247.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $247.4 million in Q4 2025 to a low of $151.9 million in Q1 2022.
- A 5-year average of $195.2 million and a median of $190.5 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets climbed 2.31% in 2024 and advanced 23.49% in 2026, its largest moves.
- Vericel's Current Assets stood at $186.9 million in 2022, then rose by 10.04% to $205.6 million in 2023, then increased by 3.48% to $212.8 million in 2024, then climbed by 16.29% to $247.4 million in 2025, then fell by 1.36% to $244.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $244.1 million, $247.4 million, and $222.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 244.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244.06 Mn |
| Dec 31, 2025 | 247.44 Mn |
| Sep 30, 2025 | 221.97 Mn |
| Jun 30, 2025 | 204.58 Mn |
| Mar 31, 2025 | 197.64 Mn |
| Dec 31, 2024 | 212.78 Mn |
| Sep 30, 2024 | 190.52 Mn |
| Jun 30, 2024 | 197.39 Mn |
| Mar 31, 2024 | 189.72 Mn |
| Dec 31, 2023 | 205.63 Mn |
| Sep 30, 2023 | 186.21 Mn |
| Jun 30, 2023 | 182.87 Mn |
| Mar 31, 2023 | 177.55 Mn |
| Dec 31, 2022 | 186.87 Mn |
| Sep 30, 2022 | 166.38 Mn |
| Jun 30, 2022 | 155.09 Mn |
| Mar 31, 2022 | 151.88 Mn |
| Dec 31, 2021 | 158.46 Mn |
| Sep 30, 2021 | 144.95 Mn |
| Jun 30, 2021 | 138.52 Mn |
| Mar 31, 2021 | 127.21 Mn |
| Dec 31, 2020 | 123.56 Mn |
| Sep 30, 2020 | 125.38 Mn |
| Jun 30, 2020 | 115.76 Mn |
| Mar 31, 2020 | 116.54 Mn |
| Dec 31, 2019 | 111.66 Mn |
| Sep 30, 2019 | 104.72 Mn |
| Jun 30, 2019 | 94.05 Mn |
| Mar 31, 2019 | 109.60 Mn |
| Dec 31, 2018 | 112.78 Mn |
| Sep 30, 2018 | 119.26 Mn |
| Jun 30, 2018 | 117.52 Mn |
| Mar 31, 2018 | 48.20 Mn |
| Dec 31, 2017 | 50.51 Mn |
| Sep 30, 2017 | 36.31 Mn |
| Jun 30, 2017 | 33.04 Mn |
| Mar 31, 2017 | 36.95 Mn |
| Dec 31, 2016 | 44.72 Mn |
| Sep 30, 2016 | 21.10 Mn |
| Jun 30, 2016 | 22.31 Mn |
| Mar 31, 2016 | 25.82 Mn |
| Dec 31, 2015 | 27.34 Mn |
| Sep 30, 2015 | 28.52 Mn |
| Jun 30, 2015 | 33.55 Mn |
| Mar 31, 2015 | 37.92 Mn |
| Dec 31, 2014 | 41.49 Mn |
| Sep 30, 2014 | 44.72 Mn |
| Jun 30, 2014 | 14.11 Mn |
| Mar 31, 2014 | 9.24 Mn |
| Dec 31, 2013 | 8.48 Mn |
| Sep 30, 2013 | 11.36 Mn |
| Jun 30, 2013 | 4.73 Mn |
| Mar 31, 2013 | 9.53 Mn |
| Dec 31, 2012 | 13.99 Mn |
| Sep 30, 2012 | 21.46 Mn |
| Jun 30, 2012 | 29.13 Mn |
| Mar 31, 2012 | 37.20 Mn |
| Dec 31, 2011 | 6.18 Mn |
| Sep 30, 2011 | 12.58 Mn |
| Jun 30, 2011 | 19.05 Mn |
| Dec 31, 2010 | 31.70 Mn |